Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Neoplasms 26 Prostatic Neoplasms 22 Colorectal Neoplasms 17 Head and Neck Neoplasms 14 Pancreatic Neoplasms 11 Lung Neoplasms 10 Brain Neoplasms 10 Neoplasm Metastasis 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 8 Melanoma 8 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma 7 Glioblastoma 7 Ovarian Neoplasms 6 Lymphoma, Follicular 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Lymphoma, B-Cell 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Kidney Neoplasms 5 Hematologic Neoplasms 5 Sarcoma 4 Liver Neoplasms 4

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Resectable Non-Small Cell Lung Cancer × 1 year × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡